Tacrolimus (FK506) monotherapy provides potent and significant suppression of allogeneic foetal rat pancreatic allograft rejection.
du Toit
D F
DF
Department of Anatomy and Histology, Faculty of Medicine, University of Stellenbosch, Tygerberg, South Africa.
Muller
C
C
Mouton
Y
Y
Page
B
B
Mattysen
J
J
Lyners
R
R
Woodroof
C
C
D000818:Animals; D016332:Fetal Tissue Transplantation / Q000276:immunology* / Q000473:pathology; D005865:Gestational Age; D006084:Graft Rejection / Q000517:prevention & control*; D006085:Graft Survival; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008214:Lymphocytes / Q000276:immunology*; D016035:Pancreas Transplantation / Q000276:immunology* / Q000473:pathology; D051381:Rats; D011919:Rats, Inbred Strains; D017207:Rats, Sprague-Dawley; D016559:Tacrolimus / Q000627:therapeutic use*; D014184:Transplantation, Homologous; D014185:Transplantation, Isogeneic
D007166:Immunosuppressive Agents; D016559:Tacrolimus